CNBX — CNBX Pharmaceuticals Inc.
$0.00
+$0.00 (+0.00%)
CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.
Market Cap
$160576.00
Forward P/E
N/A
52-Week Range
N/A
CNBX Price History
Revenue vs. Net Income
Annual. Net margin is shown under each year.
Free Cash Flow
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
